BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32936384)

  • 1. DNA methylation in the upstream CpG island of the GPER locus and its relationship with GPER expression in colon cancer cell lines.
    Pal U; Ghosh S; Limaye AM
    Mol Biol Rep; 2020 Oct; 47(10):7547-7555. PubMed ID: 32936384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Manjegowda MC; Gupta PS; Limaye AM
    Gene; 2017 May; 614():65-73. PubMed ID: 28286086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients.
    Weissenborn C; Ignatov T; Nass N; Kalinski T; Dan Costa S; Zenclussen AC; Ignatov A
    Cancer Invest; 2017 Feb; 35(2):100-107. PubMed ID: 28118074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
    Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.
    Kang YH; Bae SI; Kim WH
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma.
    Petak I; Danam RP; Tillman DM; Vernes R; Howell SR; Berczi L; Kopper L; Brent TP; Houghton JA
    Cell Death Differ; 2003 Feb; 10(2):211-7. PubMed ID: 12700649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
    Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
    Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide profiling of DNA methylation in human cancer cells.
    Ogoshi K; Hashimoto S; Nakatani Y; Qu W; Oshima K; Tokunaga K; Sugano S; Hattori M; Morishita S; Matsushima K
    Genomics; 2011 Oct; 98(4):280-7. PubMed ID: 21821115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
    Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
    Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
    Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
    Tian S; Zhan N; Li R; Dong W
    Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer.
    Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA
    Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of CpG loci in 5'-flanking region alters steady-state expression of adenomatous polyposis coli gene in colon cancer cell lines.
    Sakamoto Y; Kitazawa R; Maeda S; Kitazawa S
    J Cell Biochem; 2001; 80(3):415-23. PubMed ID: 11135372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability.
    Kang GH; Lee S; Shim YH; Kim JC; Ro JY
    Pathol Int; 2002 Dec; 52(12):764-8. PubMed ID: 12588445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.